IL12RB1 and Mendelian susceptibility to mycobacterial diseases: Even though hundreds of IL12RB1-related MSMD kindreds have been reported worldwide [5,16,17,31,32,33,34], the incomplete clinical penetrance of IL12RB1 deficiency and low recurrence rate of mycobacteria infection [16,27] suggest that protective immunity still exists in these individuals.